NCT02093598View on ClinicalTrials.gov

POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Carcinoma, EndometrioidmTOR Protein
Interventions
DRUG

Temsirolimus

Trial Locations (3)

Unknown

Barcelona

Madrid

Valencia

All Listed Sponsors
lead

MedSIR

OTHER

NCT02093598 - POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus | Biotech Hunter | Biotech Hunter